PALI

Palisade Bio Inc

• Dow Jones·2d ago

  Palisade Bio Initiated at Outperform by Wolfe Research

• TipRanks·3d ago

  Palisade Bio initiated with an Outperform at Wolfe Research

• Reuters·3d ago

  Palisade Bio to present at Needham & Co. annual healthcare conference

• TipRanks·04/04 14:50

  Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

• TipRanks·04/02 13:26

  Palisade Bio partners with Iterative Health to advance PALI-2108

• Reuters·04/02 12:35

  Palisade Bio sells 1.54 million shares in $3 million private placement to Iterative affiliate

• TipRanks·04/01 13:00

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Palisade Bio (PALI) and Moderna (MRNA)

• TipRanks·03/31 20:38

  Palisade Bio reaction to PALI-2108 data ‘looks misaligned’, says Clear Street

• Seeking Alpha·03/31 17:10

  Palisade Bio drops after early-stage trial data for lead asset

• TipRanks·03/31 14:30

  Analysts Are Bullish on Top Healthcare Stocks: Palisade Bio (PALI), Rigel (RIGL)

• TipRanks·03/31 10:50

  Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), Palisade Bio (PALI) and Eli Lilly & Co (LLY)

• NASDAQ·03/31 10:48

  Palisade Bio Reports Positive Topline Data From Phase 1b Study Of PALI-2108 In FSCD But Stock Down

• TipRanks·03/31 10:30

  Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Edwards Lifesciences (EW) and Palisade Bio (PALI)

• TipRanks·03/30 20:19

  Palisade Bio announces topline data from PALI-2108 trial

• Benzinga·03/30 20:04

  Palisade Bio Announces Topline Data From Phase 1b Clinical Study Evaluating PALI-2108, Once-Daily Oral PDE4 Inhibitor Prodrug To Be Selectively Bioactivated In Ileum And Colon, In Patients With FSCD